Samsung Biologics said it expected to post annual sales of more than 3.6 trillion won this year, up more than 20 percent from the previous year.In a public filing on Thursday, Samsung Biologics said it has raised its annual sales growth outlook for 2023 by more than 20 percent, instead of the previo
The number of osteoporosis patients is approaching 1.2 million a year, but the budget for developing and disseminating osteoporosis guidelines has been cut in full.Rep. In Jae-geun of the Democratic Party of Korea said so Wednesday after analyzing data from the Korea Disease Control and Prevention A
GSK Korea said on Wednesday that it appointed Maurizio Borgatta as its new general manager as of Oct. 1.Borgatta will fill the shoes of outgoing GSK Korea General Manager, Rob Kempton, who has led GSK Korea since 2020. Subsequently, Kempton will serve as Head of the Vaccines Market in Europe.Since j
Handok said on Wednesday that it entered into a strategic partnership with global biopharmaceutical company Sobi to strengthen its rare disease business. Sobi, a Swedish biopharmaceutical specializing in rare diseases, provides innovative therapies in hematology, immunology, and specialty care, with
Korean pharmaceutical companies are stepping up competition to develop microneedle patch-type obesity treatments, often called “adhesive obesity drugs.”Four companies -- Daewon Pharmaceutical, Dong-A ST, Kwangdong Pharmaceutical, and Daewoong Group – have joined the competition.According to industry
In the aftermath of Covid-19, Korea's national health insurance system has attracted the attention of developing countries.The National Health Insurance Service (NHIS) held the 20th International Training Course on Health Insurance from Sept. 15 to 20 with the attendance of health officials and infl
Celltrion said on Wednesday that it received approval from the FDA for its 80 mg and 20 mg dosage forms of Yuflyma, a biosimilar referencing Abbvie's Humira (ingredient: adalimumab), adding to the existing approval for the 40 mg dose. Humira, the original medicine, is prescribed primarily for autoim
TiumBio announced on Sunday the fourth-quarter global clinical trial updates for its lead pipelines, including its endometriosis drug candidate TU2670.TiumBio is currently conducting a phase 2a clinical trial of TU2670 in endometriosis patients in Europe, with plans to generate European top-line dat
Roche Korea said on Wednesday that its oral treatment for spinal muscular atrophy (SMA), Evrysdi (ingredient: risdiplam), obtained health insurance coverage from Oct.1.Accordingly, Evrysdi will be covered for patients with 5q SMA with a confirmed genetic diagnosis of a deletion or mutation in the 5q
In a country where speed is emphasized as a way of life, it is uncommon to talk about Korea being slow at doing something. However, this is the case with malaria treatment in the country, as Korean physicians lack experience due to the relatively low annual caseload.Unlike Korea, malaria generally h
For many, the term migraine simply implies a severe headache. But for millions worldwide, it represents a debilitating condition that significantly impacts their quality of life, often resulting in absenteeism, reduced productivity, and social isolation.As the World Health Organization ranks migrain
From June 2022 to May 2023, 5,997 poisoned patients visited 15 emergency medical centers in 14 cities and provinces nationwide. More than half of them were addicted to therapeutic drugs.On Wednesday, the Korea Disease Control and Prevention Agency (KDCA) released the results of its in-depth survey o
A research team Korea Advanced Institute of Science and Technology (KAIST) has leveraged artificial intelligence (AI) to find a potential cause and treatment for schizophrenia.Schizophrenia is a mental disorder characterized by hallucinations, delusions, and cognitive disabilities. Schizophrenia has
Yonsei University Health System (YUHS) has earned recognition from Nature, one of the world's premier scientific journals, as one of the "Top 100 Leading Cancer Research Hospitals of 2023."YUHS stands as the sole Korean hospital on this prestigious list, securing the 78th position.Nature bases its a
Daewoong Bio, whose flagship products include choline alfoscerates, is entering the health-functional food business.Industry executives watch with interest whether the company could find a new path, overcoming the crisis caused by reduced health insurance benefits for choline alfoscerates.Daewoong B
The digital healthcare scene is also bustling ahead of the super-aged society. As “senior” healthcare and welfare have emerged as a social issue, leading healthcare technology companies based on artificial intelligence, virtual reality, and metaverse are also paying attention to this trend. Some hav
Handok said on Wednesday that it submitted an IND plan for a global phase 2/3 clinical trial of HDB001A, a biliary tract cancer drug candidate, to the Ministry of Food and Drug Safety (MFDS). The global phase 2/3 study of HDB001A will enroll 150 patients at more than 35 sites in Korea and overseas.
Sejong Medical said it has been suspended from manufacturing its disposable guide needles for three months by the Ministry of Food and Drug Safety after failing to obtain authorization after a change in the device's approval status. The administrative action will be enforced from Thursday to Dec. 27
Bridge Biotherapeutics announced on Tuesday that it will discontinue the development of BBT-176, a drug candidate for non-small cell lung cancer (NSCLC), and BBT-212, another candidate for fundus disease.Instead, the company stated it would focus on BBT-877 and BBT-207, candidates for idiopathic pul
The Korean government decided to keep the health insurance premiums unchanged at 7.09 percent for 2024 due to high inflation and interest rates. The Ministry of Health and Welfare announced that it convened a meeting of the health insurance policy deliberation committee on Tuesday afternoon and dete